THE CONTINUUM OF CARE IN HOSPITALIZED PATIENTS WITH OPIOID USE DISORDER AND INFECTIOUS COMPLICATIONS OF DRUG USE (CHOICE)
THE CONTINUUM OF CARE IN HOSPITALIZED PATIENTS WITH OPIOID USE DISORDER AND INFECTIOUS COMPLICATIONS OF DRUG USE (CHOICE)
批准号:
10717509
负责人:
MATTHEW KIRKBY
金额:
$233.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-01 至 2028-08-31
关键词:
Academic Medical CentersAddressAftercareAlabamaBacterial InfectionsBaltimoreCaringCommunicable DiseasesComplicationConsultContinuity of Patient CareDistrict of ColumbiaDrug usageEffectiveness of InterventionsEpidemicGoalsHIVHealthcareHelping to End Addiction Long-termHepatitis C virusHospitalizationHospitalsIndividualInfectionInfective endocarditisInpatientsInterventionInvestigationLocationMarylandMedicaidMedicalMedical centerModelingOpiate AddictionOpioidOutcomeOutpatientsPatientsPharmaceutical PreparationsPublic HealthResearchRural PopulationSpeedSystemTimeUnited StatesUnited States National Institutes of HealthUniversitiesUniversity HospitalsWashingtonaddictionhigh riskimprovedimproved outcomemultidisciplinaryopioid epidemicopioid misuseopioid use disorderpreventuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In the United States, there is an opioid epidemic which is associated with acquisition of HIV, HCV and STIs, as well as rising rates of infective endocarditis and systemic bacterial infections.(1-3) Given the clear intersection of these parallel epidemics of infectious diseases and opioid use disorder, it is critical that we identify models of care which prevent acquisition of these infections and enhance treatment of existing infections by addressing opioid use disorder throughout the continuum of care.(4,5) Many individuals with opioid use disorder (OUD) are not engaged in medical care, therefore, inpatient hospitalization represents an opportune time to initiate treatment and engagement among these high risk individuals. However, inpatient interventions to address addiction are often suboptimal, incomplete, or limited to the time of hospitalization.(6) Further, observational investigations in individual hospital systems have demonstrated the effectiveness of interventions, including addiction consult teams, multidisciplinary rounds, and linkage navigators, in increasing uptake of medications for opioid use disorder during hospitalization and linkage into addictions treatment after discharge. However, there have been no multi-center investigations to rigorously evaluate the impact of these interventions on long term infectious outcomes.
This study is part of the NIH’s Helping to End Addiction Long-term (HEAL) initiative to speed scientific solutions to the national opioid public health crisis. The NIH HEAL Initiative bolsters research across NIH to improve treatment for opioid misuse and addiction
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
REGULATORY MANAGEMENT CENTER (RMC)
-
批准号:10672004
-
项目类别:
-
资助金额:$100.0万
-
财政年份:2021
-
负责人:MATTHEW KIRKBY
-
依托单位:
REGULATORY MANAGEMENT CENTER (RMC) - Infectious Diseases
-
批准号:10788219
-
项目类别:
-
资助金额:$419.75万
-
财政年份:2021
-
负责人:MATTHEW KIRKBY
-
依托单位:
REGULATORY MANAGEMENT CENTER (RMC) - Infectious Diseases
-
批准号:10666940
-
项目类别:
-
资助金额:$199.27万
-
财政年份:2021
-
负责人:MATTHEW KIRKBY
-
依托单位:
CLINICAL CENTRAL LABORATORY SERVICES
-
批准号:10397350
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2021
-
负责人:MATTHEW KIRKBY
-
依托单位:
REGULATORY MANAGEMENT CENTER (RMC)
-
批准号:10688710
-
项目类别:
-
资助金额:$109.16万
-
财政年份:2021
-
负责人:MATTHEW KIRKBY
-
依托单位:
FY19 TRIAL EXECUTION OPTION ITEM #2 - KENNY-PHASE I SINGLE ASCENDING DOSE STUDY-BPN-19302 (AZD4041) PROTOCOL DEVELOPMENT AND FINALIZATION AND DATABASE BUILD AND BIOANALYTICAL METHODS DEVELOPMENT FOR C
-
批准号:10263137
-
项目类别:
-
资助金额:$47.68万
-
财政年份:2019
-
负责人:MATTHEW KIRKBY
-
依托单位:
BUCKPITT-PHASE I SINGLE ASCENDING DOSE STUDY-BPN-19186 (EC5026) PROTOCOL DEVELOPMENT AND FINALIZATION AND DATABASE BUILD AND BIOANALYTICAL METHODS DEVELOPMENT FOR CLINICAL TRIAL EXECUTION
-
批准号:10074459
-
项目类别:
-
资助金额:$170.6万
-
财政年份:2019
-
负责人:MATTHEW KIRKBY
-
依托单位:
Clinical Central Laboratory Services to support a VTEU trial for an Influenza vaccine
-
批准号:10004795
-
项目类别:
-
资助金额:$8.17万
-
财政年份:2019
-
负责人:MATTHEW KIRKBY
-
依托单位:--
CLINICAL CENTRAL LABORATORY SERVICES
-
批准号:9568148
-
项目类别:
-
资助金额:$14.04万
-
财政年份:2017
-
负责人:MATTHEW KIRKBY
-
依托单位:--
FY19 TRIAL EXECUTION OPTION ITEM #2 - KENNY-PHASE I SINGLE ASCENDING DOSE STUDY-BPN-19302 (AZD4041) PROTOCOL DEVELOPMENT AND FINALIZATION AND DATABASE BUILD AND BIOANALYTICAL METHODS DEVELOPMENT FOR C
-
批准号:10031231
-
项目类别:
-
资助金额:$95.48万
-
财政年份:2016
-
负责人:MATTHEW KIRKBY
-
依托单位:
BUCKPITT-PHASE I SINGLE ASCENDING DOSE STUDY-BPN-19186 (EC5026) PROTOCOL DEVELOPMENT AND FINALIZATION AND DATABASE BUILD AND BIOANALYTICAL METHODS DEVELOPMENT FOR CLINICAL TRIAL EXECUTION
-
批准号:10031222
-
项目类别:
-
资助金额:$38.7万
-
财政年份:2016
-
负责人:MATTHEW KIRKBY
-
依托单位:
Cancer Trials Support Unit(CTSU), Exceptional Responders Initiative
-
批准号:8948898
-
项目类别:
-
资助金额:$5.92万
-
财政年份:2014
-
负责人:MATTHEW KIRKBY
-
依托单位:
海外基金